WinstonWınston
Centene logo

Centene

CNC
24
Medical - Healthcare Plans · Healthcare
Price
$66.44
+2.55 (+3.99%)
Market Cap
$32.81B
Winston Score
24
Winston is worried
Weak fundamentals across most pillars.

Share count falling — buybacks

16.8% over 4y

The company has reduced its share count over this period, returning value to shareholders through buybacks.

Diluted shares outstanding: 590.5M (2021) → 491.1M (2025)

Centene Corporation is a large health insurance company that manages government-sponsored healthcare programs. Its main products are health plans sold through Medicaid, Medicare, and the Affordable Care Act marketplace. The company's customers are mostly low-income individuals, elderly people, and others who rely on government programs to pay for their healthcare.

Centene makes money by receiving fixed payments from federal and state governments for each enrolled member, then paying out claims when those members use medical services. It operates across all 50 U.S. states and is one of the largest Medicaid managed care companies in the country, giving it significant scale. However, the company is currently losing money at the operating level, and its biggest risk is that medical costs are rising faster than the government reimbursement rates it receives — a problem that has pressured margins across the managed care industry and will require either cost controls or favorable rate updates to resolve.

Winston Score History

Politician Trades

20 trades / 12mo

15 Congressional buys and 5 sells on CNC in the last 12 months.

Unlock the full Smart Money Map — every trade plotted on the price chart with politicians, amounts and returns since each trade. Founder's Deal is $57/mo locked for life.

Unlock politician trades

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+7.1% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+18.6% YoY

YoY Growth Rate

Steady EPS growth

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

7.1%ownership

Flat

Insiders holding steady — not selling despite ability to

Cash Position

Cash flow positive

$21.3B cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

Centene is growing revenue at 7% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
21.9%
Thin — 21.9% gross margin
Operating Margin
3.7%
Thin — 3.7% operating margin
ROCE
4.9%
Weak — 4.9% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
+17.0%
Fast-growing sales (17.0% YoY)
EPS YoY
-294.7%
Earnings shrinking (-294.7% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

EPS Consistency
2/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
N/A
Data not available
FCF Margin
3.2%
Thin free cash flow (3.2%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
0.76
Moderate — manageable debt (0.76)
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial